Clinical Trial Update: Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma

View source ↗

Summary

This clinical trial update describes the performance evaluation of a urine-based methylation assay for urothelial carcinoma. The study status is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Urine-based methylation assay for urothelial carcinoma

Snippet

Sponsor: Shanghai Epiprobe Biotechnology Co., Ltd. | Conditions: Urothelial Carcinoma | Status: NOT_YET_RECRUITING